Cargando…

Corrigendum: Unfractionated and Low-Molecular-Weight Heparin and the Phosphodiesterase Inhibitors, IBMX and Cilostazol, Block Ex Vivo Equid Herpesvirus Type-1-Induced Platelet Activation

Detalles Bibliográficos
Autores principales: Stokol, Tracy, Serpa, Priscila B. S., Zahid, Muhammad N., Brooks, Marjory B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302014/
https://www.ncbi.nlm.nih.gov/pubmed/28194402
http://dx.doi.org/10.3389/fvets.2017.00010
_version_ 1782506464663830528
author Stokol, Tracy
Serpa, Priscila B. S.
Zahid, Muhammad N.
Brooks, Marjory B.
author_facet Stokol, Tracy
Serpa, Priscila B. S.
Zahid, Muhammad N.
Brooks, Marjory B.
author_sort Stokol, Tracy
collection PubMed
description
format Online
Article
Text
id pubmed-5302014
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-53020142017-02-13 Corrigendum: Unfractionated and Low-Molecular-Weight Heparin and the Phosphodiesterase Inhibitors, IBMX and Cilostazol, Block Ex Vivo Equid Herpesvirus Type-1-Induced Platelet Activation Stokol, Tracy Serpa, Priscila B. S. Zahid, Muhammad N. Brooks, Marjory B. Front Vet Sci Veterinary Science Frontiers Media S.A. 2017-02-10 /pmc/articles/PMC5302014/ /pubmed/28194402 http://dx.doi.org/10.3389/fvets.2017.00010 Text en Copyright © 2017 Stokol, Serpa, Zahid and Brooks. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Veterinary Science
Stokol, Tracy
Serpa, Priscila B. S.
Zahid, Muhammad N.
Brooks, Marjory B.
Corrigendum: Unfractionated and Low-Molecular-Weight Heparin and the Phosphodiesterase Inhibitors, IBMX and Cilostazol, Block Ex Vivo Equid Herpesvirus Type-1-Induced Platelet Activation
title Corrigendum: Unfractionated and Low-Molecular-Weight Heparin and the Phosphodiesterase Inhibitors, IBMX and Cilostazol, Block Ex Vivo Equid Herpesvirus Type-1-Induced Platelet Activation
title_full Corrigendum: Unfractionated and Low-Molecular-Weight Heparin and the Phosphodiesterase Inhibitors, IBMX and Cilostazol, Block Ex Vivo Equid Herpesvirus Type-1-Induced Platelet Activation
title_fullStr Corrigendum: Unfractionated and Low-Molecular-Weight Heparin and the Phosphodiesterase Inhibitors, IBMX and Cilostazol, Block Ex Vivo Equid Herpesvirus Type-1-Induced Platelet Activation
title_full_unstemmed Corrigendum: Unfractionated and Low-Molecular-Weight Heparin and the Phosphodiesterase Inhibitors, IBMX and Cilostazol, Block Ex Vivo Equid Herpesvirus Type-1-Induced Platelet Activation
title_short Corrigendum: Unfractionated and Low-Molecular-Weight Heparin and the Phosphodiesterase Inhibitors, IBMX and Cilostazol, Block Ex Vivo Equid Herpesvirus Type-1-Induced Platelet Activation
title_sort corrigendum: unfractionated and low-molecular-weight heparin and the phosphodiesterase inhibitors, ibmx and cilostazol, block ex vivo equid herpesvirus type-1-induced platelet activation
topic Veterinary Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302014/
https://www.ncbi.nlm.nih.gov/pubmed/28194402
http://dx.doi.org/10.3389/fvets.2017.00010
work_keys_str_mv AT stokoltracy corrigendumunfractionatedandlowmolecularweightheparinandthephosphodiesteraseinhibitorsibmxandcilostazolblockexvivoequidherpesvirustype1inducedplateletactivation
AT serpapriscilabs corrigendumunfractionatedandlowmolecularweightheparinandthephosphodiesteraseinhibitorsibmxandcilostazolblockexvivoequidherpesvirustype1inducedplateletactivation
AT zahidmuhammadn corrigendumunfractionatedandlowmolecularweightheparinandthephosphodiesteraseinhibitorsibmxandcilostazolblockexvivoequidherpesvirustype1inducedplateletactivation
AT brooksmarjoryb corrigendumunfractionatedandlowmolecularweightheparinandthephosphodiesteraseinhibitorsibmxandcilostazolblockexvivoequidherpesvirustype1inducedplateletactivation